Sprint Bioscience AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sprint Bioscience AB with three other
companies in this sector in Sweden:
sales of 22.87 million Swedish Kronor [US$2.50 million]
of which 100%
was Medical Research Tools),
(20.69 million Swedish Kronor [US$2.26 million]
Xbrane Biopharma Ab
(20.77 million Swedish Kronor [US$2.27 million]
of which 108%
was Long-acting injectables).